NC

Nitin Chawla

Active Director Director DIN 00523870
DIN 00523870 First appointment Dec 1995 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 1995
Shareholding value •••• Premium profile

About Nitin Chawla

Data last updated:

Nitin Chawla is a Director at Naman Medicine Private Limited (since 1995). The company operates in Trading. Naman Medicine Private Limited reported revenue of ₹5.18 Cr (FY 2025).

DIN 00523870
Primary Designation Director
Industry Trading
First Appointment 13 Dec 1995
Oldest Company Age 30 yrs
Largest company Naman Medicine Private Limited · ₹5.18 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Naman Medicine Private Limited U74899DL1995PTC074597
Director13 Dec 19951995₹5.18 Cr (FY 2025)Active

Board colleagues of Nitin Chawla

NameDINCompanyDesignation
Nikhil Chawla00512408Naman Medicine Private LimitedDirector

Directorship timeline

Open interactive timeline →
Naman Medicine Private Limited
Premium access

Shareholding and investment profile for Nitin Chawla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nitin Chawla

Nitin Chawla currently holds 1 directorship: Naman Medicine Private Limited (Director, since 13 Dec 1995, revenue ₹5.18 Cr (FY 2025)).

Nitin Chawla was first appointed on 13 Dec 1995 as Director at Naman Medicine Private Limited.

The current boards of Nitin Chawla's companies include Nikhil Chawla (Naman Medicine Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available